GCP
GPCR icon

GSA Capital Partners’s Structure Therapeutics GPCR Stock Holding History

GSA Capital Partners’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$666K Buy
+13,811
New +$945K 0.04% 739
2025
Q4 		– Sell
-9,886
Closed -$277K – 1822
2025
Q3 		$277K Buy
+9,886
New +$197K 0.02% 1247
2024
Q4 		– Sell
-30,464
Closed -$1.34M – 1755
2024
Q3 		$1.34M Buy
+30,464
New +$1.18M 0.1% 297

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

GSA Capital Partners's GPCR Position: Q1 2026 in Review

GSA Capital Partners opened a new position in Structure Therapeutics (GPCR) in Q1 2026: 13,811 shares worth $666K. The stake represents 0.04% of the portfolio and ranks #739 among its holdings. This is a return to the name: GSA Capital Partners previously reported a position in GPCR as recently as Q3 2025.

GSA Capital Partners first reported a position in GPCR in Q3 2024 and has held it in 3 quarters since. The position peaked at $1.34M in Q3 2024. 196 funds tracked by Wall St. Rank hold GPCR as of Q1 2026.

  • GSA Capital Partners held 13,811 shares of Structure Therapeutics worth $666K as of Q1 2026.
  • Structure Therapeutics was a new GSA Capital Partners position in Q1 2026.
  • Structure Therapeutics made up 0.04% of GSA Capital Partners's portfolio in Q1 2026, its #739 holding.
  • GSA Capital Partners first reported a position in Structure Therapeutics in Q3 2024 and has held it in 3 quarters since.
  • GSA Capital Partners's Structure Therapeutics position peaked at $1.34M in Q3 2024.
  • 196 funds tracked by Wall St. Rank held Structure Therapeutics as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.